HCA(US:HCA) ZACKS·2026-01-27 14:10分组1 - HCA Healthcare reported quarterly earnings of $8.01 per share, exceeding the Zacks Consensus Estimate of $7.36 per share, and up from $6.22 per share a year ago, representing an earnings surprise of +8.90% [1] - The company posted revenues of $19.51 billion for the quarter ended December 2025, which was 0.63% below the Zacks Consensus Estimate, and an increase from $18.29 billion year-over-year [2] - HCA has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3] - HCA shares have gained approximately 1.2% since the beginning of the year, compared to a 1.5% gain in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $7.06 on revenues of $19.26 billion, and for the current fiscal year, it is $29.59 on revenues of $79.3 billion [7] 分组3 - The Zacks Industry Rank indicates that the Medical Services sector is currently in the bottom 25% of over 250 Zacks industries, which may negatively impact stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5] - HCA's current Zacks Rank is 4 (Sell), indicating expectations of underperformance in the near future [6]